L-arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats.
about
Preeclampsia: long-term consequences for vascular healthImpaired adenosine-mediated angiogenesis in preeclampsia: potential implications for fetal programmingThe therapeutic potential of antioxidants, ER chaperones, NO and H2S donors, and statins for treatment of preeclampsia.Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndromeReduced uterine perfusion pressure induces hypertension in the pregnant mouse.SFlt-1 elevates blood pressure by augmenting endothelin-1-mediated vasoconstriction in mice.From Pre-Clinical Studies to Clinical Trials: Generation of Novel Therapies for Pregnancy Complications.A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model.Immune Mechanisms Linking Obesity and Preeclampsia.Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms.Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia.Obese melanocortin-4 receptor-deficient rats exhibit augmented angiogenic balance and vasorelaxation during pregnancy.Enhanced endothelin receptor type B-mediated vasodilation and underlying [Ca²⁺]i in mesenteric microvessels of pregnant rats.The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia.New Models of Pregnancy-Associated Hypertension.Pathophysiology and Current Clinical Management of Preeclampsia.Nitric oxide synthase-mediated blood pressure regulation in obese melanocortin-4 receptor-deficient pregnant rats.Serelaxin improves the pathophysiology of placental ischemia in the reduced uterine perfusion pressure rat model of preeclampsia.Continued Investigation Into 17-OHPC: Results From the Preclinical RUPP Rat Model of Preeclampsia.Soluble Flt-1 links microvascular disease with heart failure in CKD.AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats.
P2860
Q26800272-9D6DD482-1D7C-448E-88B6-A8D93C52A1CDQ27024603-38AD6EEF-3C96-489C-9832-974938FDAB0DQ33668328-1ABBF47D-436D-4D5C-BA14-F04A0448A0BAQ34025660-6275112C-875A-423B-BA8F-DF45FB3F0EA2Q34627421-B0DAF33C-DBDB-4A09-A960-546525A95C1AQ35121861-6F48B81B-C320-4500-8F47-C8274B6762C5Q35813932-AC69DAA3-8D59-48E0-A63B-B9BE1E10C294Q36115311-41381D45-60A4-464C-981E-9CF7BABA4DB6Q36409599-1EA307B7-C456-4112-B2B0-621EFA7AFECFQ36422496-D21FA2D2-0D25-4ECA-9F54-F83A311DB3DAQ37229246-DA684C06-8856-40A8-8FC2-0AF0BAE34F6EQ37244977-5A93B1E1-B024-4B06-BD65-305550A6F801Q37318884-64F5ED1F-8DF0-40FF-9E77-5A6118B013ABQ38693025-8DB90DE3-42E4-4ECB-997A-AC75BC9EAA36Q39283914-E502BAF4-C426-41D5-B2CC-C339FC19FE4CQ39423454-7D3E00EB-8EA7-4B70-9017-734E805B5CBAQ42784324-63D9C502-FB6C-4921-86DA-B8708512B5FDQ45350029-5C2F8E76-B7AC-4D86-92F0-E6E6B0BDB86CQ47688833-F7D30AD5-999A-43BB-8F03-984EF926C31DQ53536660-2350685B-C84C-477A-B568-C408B14A6A88Q53700889-A82DE3D9-C6F5-4EB3-A817-73B9889BF19D
P2860
L-arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
L-arginine supplementation abo ...... lasma sFlt-1 in pregnant rats.
@ast
L-arginine supplementation abo ...... lasma sFlt-1 in pregnant rats.
@en
type
label
L-arginine supplementation abo ...... lasma sFlt-1 in pregnant rats.
@ast
L-arginine supplementation abo ...... lasma sFlt-1 in pregnant rats.
@en
prefLabel
L-arginine supplementation abo ...... lasma sFlt-1 in pregnant rats.
@ast
L-arginine supplementation abo ...... lasma sFlt-1 in pregnant rats.
@en
P2093
P2860
P1476
L-arginine supplementation abo ...... lasma sFlt-1 in pregnant rats.
@en
P2093
Babbette LaMarca
Joey P Granger
Kathy Cockrell
Marietta Arany
Sydney R Murphy
P2860
P304
P356
10.1152/AJPREGU.00319.2011
P577
2011-11-09T00:00:00Z